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Sir, 
Staphylococcus pseudintermedius is the most frequent causative agent of canine pyoderma 
and may also be associated with wound infections, urinary tract infections and otitis externa 
in dogs.
1
 Although more rarely,S. pseudintermedius causes infections in cats and has also 
been identified in infections of humans.
1–3
 The latter observation highlights the zoonotic 
potential of S. pseudintermedius. S. pseudintermedius appears to be able to readily 
accumulate antimicrobial resistance genes
1,4
 and, in recent years, a rapid increase in 
methicillin resistance has been observed.
5,6
 A recent multicentre study on methicillin-
resistant S. pseudintermedius(MRSP) of canine origin, obtained in different European 
countries as well as in the USA and Canada, revealed that most of the canine strains exhibited 
resistance to virtually all classes of antimicrobial agents approved for veterinary use.4 This 
represents a major therapeutic challenge for veterinarians in Europe and North America. 
Moreover, this multicentre study revealed that among MRSP from dogs two distinct, 
dominant clones—as identified by multilocus sequence typing (MLST), spatyping, 
SCCmec typing and SmaI PFGE—have disseminated across Europe and North America.4 In 
contrast to the wealth of data available for MRSP isolates of canine origin, little data are 
available about MRSP from cats. 
The aim of the present study was to characterize MRSP isolates from cats in different 
countries for their genetic relationships and antimicrobial resistance phenotypes and 
genotypes. Twelve epidemiologically unrelated MRSP isolates of feline origin were 
identified during 2006–08 in five different countries (Table 1). Eleven isolates were from 
clinical disease conditions, including septicaemia, urinary tract infections, nephritis, rhinitis, 
wound infection and pneumonia. The remaining isolate was obtained from a nasal swab of an 
apparently healthy cat (Table 1). All isolates were confirmed to be S. pseudintermedius by 
MboI digestion of a PCR-amplified internal fragment of the pta gene.
4
 For a better 
comparison with data of canine MRSP isolates, MLST,
7
 spa typing,
8
 SmaI PFGE and 
SCCmec typing was performed as recently described.
4
 MICs of 17 antimicrobial agents were 
determined using the VetMIC™ microdilution panels (National Veterinary Institute, Uppsala, 
Sweden) as previously described and evaluated using the breakpoints of the CLSI.4 MICs of 
rifampicin, mupirocin and quinupristin/dalfopristin were determined by Etest
®
 (AB Biodisk, 
Solna, Sweden). Antibiotic resistance genes were detected using either a microarray or 
specific PCR assays as described previously.
4 
All 12 feline S. pseudintermedius proved to be MRSP by oxacillin MICs of >16 mg/L and 
carriage of the mecA gene. Despite the diverse geographical origins, the 11 European MRSP 
isolates shared the same MLST type ST71, spa type t02 and SCCmec type II–III. 
SCCmec type II–III is a hybrid of SCCmec II (2A) from Staphylococcus epidermidis and 
SCCmec III from Staphylococcus aureus.
9
 PFGE analysis identified three different patterns J, 
N and O among these European feline MRSP isolates. The single MRSP isolate from Canada 
harboured an SCCmec type V element and exhibited spa type t23, MLST type ST100 and 
PFGE pattern B. A comparison with the data of the multicentre study on MRSP in dogs
4
 
revealed that PFGE patterns B, N and O were exclusive to feline MRSP isolates whereas 
pattern J was the dominant PFGE pattern among European canine MRSP.
4
 The Canadian 
feline MRSP isolate also differed largely in its resistance phenotype and genotype from the 
European feline MRSP isolates. It was only resistant to β-lactam antibiotics 
via mecA andblaZ, and to tetracyclines via tet(M). In contrast, the European isolates exhibited 
three different expanded resistance phenotypes and genotypes (Table 1). All isolates were 
resistant to β-lactam antibiotics (mecA, blaZ), macrolides/lincosamides [erm(B)], 
gentamicin/kanamycin [aac(6′)-Ie/aph(2′)-Ia], kanamycin [aph(3′)-III], streptomycin 
[ant(6′)-Ia], trimethoprim [dfrG] and ciprofloxacin. Moreover, all but one isolate from 
Switzerland and all but two isolates from Switzerland and the Netherlands were resistant to 
chloramphenicol (catpC221) and to tetracyclines [tet(K)], respectively. However, all feline 
MRSP isolates were susceptible to mupirocin, rifampicin, quinupristin/dalfopristin, linezolid 
and vancomycin, which are important for decolonization of humans or represent 
‘antimicrobial agents of last resort’ for the treatment of methicillin-resistant S. 
aureus (MRSA) infections in humans. 
A comparison with the results of the genetic analysis of canine MRSP showed that the 
Canadian feline MRSP differed in all characteristics, except SCCmec type V, from the 
dominant canine MRSP clone in North America, which is characterized by ST68 (MLST)–C 
(PFGE)–t06 (spa)–V (SCCmec).4 In contrast, 9 of the 11 European feline MRSP isolates 
were identified as members of the previously described dominant clonal lineage among 
canine MRSP in Europe, which is characterized by ST71 (MLST)–J (PFGE)–t02 (spa)–II–III 
(SCCmec).
4
 This observation strongly suggested an exchange of MRSP isolates between dogs 
and cats in Europe. Whether the feline MRSP isolate from Canada represents a member of a 
new MRSP clone with a particular tropism for cats remains to be determined. 
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Tab.1 
Legend - Characteristics of the 12 MRSP isolates from cats investigated in this study 
 
a
I, Italy; CH, Switzerland; NL, the Netherlands; D, Germany; CAN, Canada. 
b
BLA, b-lactam antibiotics; CHL, chloramphenicol; FQ, fluoroquinolones; GEN, gentamicin; 
KAN, kanamycin; ML, macrolides/lincosamides; STR, streptomycin; TET, tetracyclines; 
TMP, trimethoprim. 
